BlackRock Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$63,119,929
-3.1%
6,921,045
+12.4%
0.00%0.0%
Q2 2023$65,145,312
-0.8%
6,157,402
+14.7%
0.00%0.0%
Q1 2023$65,666,626
+2.5%
5,369,307
+4.0%
0.00%0.0%
Q4 2022$64,070,795
-3.9%
5,162,836
+5.8%
0.00%0.0%
Q3 2022$66,650,000
-26.7%
4,879,308
-1.7%
0.00%
-33.3%
Q2 2022$90,957,000
+14.3%
4,962,089
+0.3%
0.00%
+50.0%
Q1 2022$79,554,000
+11.5%
4,947,345
-2.9%
0.00%0.0%
Q4 2021$71,330,000
-23.9%
5,095,026
+1.9%
0.00%
-33.3%
Q3 2021$93,678,000
-9.5%
5,001,416
+0.8%
0.00%0.0%
Q2 2021$103,466,000
-29.9%
4,962,381
-5.0%
0.00%
-25.0%
Q1 2021$147,669,000
-8.3%
5,223,546
+5.9%
0.00%
-20.0%
Q4 2020$161,079,000
+19.9%
4,931,956
+12.5%
0.01%0.0%
Q3 2020$134,329,000
+90.0%
4,384,104
+1.1%
0.01%
+66.7%
Q2 2020$70,701,000
+141.1%
4,337,512
+47.1%
0.00%
+200.0%
Q1 2020$29,329,000
-28.8%
2,947,766
-1.5%
0.00%
-50.0%
Q4 2019$41,164,000
-8.7%
2,993,752
+0.7%
0.00%0.0%
Q3 2019$45,088,000
-4.9%
2,972,189
+23.5%
0.00%0.0%
Q2 2019$47,396,000
+21.8%
2,407,038
+2.6%
0.00%0.0%
Q1 2019$38,918,000
+15.0%
2,345,783
-2.7%
0.00%0.0%
Q4 2018$33,836,000
-19.3%
2,409,979
+0.6%
0.00%0.0%
Q3 2018$41,932,000
+15.1%
2,396,137
+19.7%
0.00%0.0%
Q2 2018$36,440,000
+21.8%
2,002,265
+25.5%
0.00%
+100.0%
Q1 2018$29,910,000
+28.2%
1,595,302
+4.6%
0.00%0.0%
Q4 2017$23,331,000
+52.6%
1,524,817
+49.1%
0.00%0.0%
Q3 2017$15,287,000
+176.3%
1,022,521
+71.9%
0.00%
Q2 2017$5,532,000
+1512.8%
594,895
+1427.1%
0.00%
Q1 2017$343,00038,9570.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders